407 related articles for article (PubMed ID: 36093200)
1. The mechanism of berberine alleviating metabolic disorder based on gut microbiome.
Wang H; Zhang H; Gao Z; Zhang Q; Gu C
Front Cell Infect Microbiol; 2022; 12():854885. PubMed ID: 36093200
[TBL] [Abstract][Full Text] [Related]
2. The combination of berberine and evodiamine ameliorates high-fat diet-induced non-alcoholic fatty liver disease associated with modulation of gut microbiota in rats.
Dai Y; Zhu W; Zhou J; Shen T
Braz J Med Biol Res; 2022; 55():e12096. PubMed ID: 35584453
[TBL] [Abstract][Full Text] [Related]
3. Berberine alleviates type 2 diabetic symptoms by altering gut microbiota and reducing aromatic amino acids.
Yao Y; Chen H; Yan L; Wang W; Wang D
Biomed Pharmacother; 2020 Nov; 131():110669. PubMed ID: 32937246
[TBL] [Abstract][Full Text] [Related]
4. Berberine alleviates intestinal barrier dysfunction in glucolipid metabolism disorder hamsters by modulating gut microbiota and gut-microbiota-related tryptophan metabolites.
Chen Y; Hao Z; Zhao H; Duan X; Jia D; Li K; Yang Y; Cui H; Gao M; Zhao D
J Sci Food Agric; 2023 Feb; 103(3):1464-1473. PubMed ID: 36168925
[TBL] [Abstract][Full Text] [Related]
5. Multi-target regulation of intestinal microbiota by berberine to improve type 2 diabetes mellitus.
He Q; Dong H; Guo Y; Gong M; Xia Q; Lu F; Wang D
Front Endocrinol (Lausanne); 2022; 13():1074348. PubMed ID: 36465656
[TBL] [Abstract][Full Text] [Related]
6. Berberine in Non-Alcoholic Fatty Liver Disease-A Review.
Koperska A; Wesołek A; Moszak M; Szulińska M
Nutrients; 2022 Aug; 14(17):. PubMed ID: 36079717
[TBL] [Abstract][Full Text] [Related]
7. Gut microbiota specifically mediates the anti-hypercholesterolemic effect of berberine (BBR) and facilitates to predict BBR's cholesterol-decreasing efficacy in patients.
Wu C; Zhao Y; Zhang Y; Yang Y; Su W; Yang Y; Sun L; Zhang F; Yu J; Wang Y; Guo P; Zhu B; Wu S
J Adv Res; 2022 Mar; 37():197-208. PubMed ID: 35499044
[TBL] [Abstract][Full Text] [Related]
8. A Holistic View of Berberine Inhibiting Intestinal Carcinogenesis in Conventional Mice Based on Microbiome-Metabolomics Analysis.
Chen H; Zhang F; Zhang J; Zhang X; Guo Y; Yao Q
Front Immunol; 2020; 11():588079. PubMed ID: 33072135
[TBL] [Abstract][Full Text] [Related]
9. Berberine Slows the Progression of Prediabetes to Diabetes in Zucker Diabetic Fatty Rats by Enhancing Intestinal Secretion of Glucagon-Like Peptide-2 and Improving the Gut Microbiota.
Wang Y; Liu H; Zheng M; Yang Y; Ren H; Kong Y; Wang S; Wang J; Jiang Y; Yang J; Shan C
Front Endocrinol (Lausanne); 2021; 12():609134. PubMed ID: 34025574
[TBL] [Abstract][Full Text] [Related]
10. Berberine ameliorates DSS-induced intestinal mucosal barrier dysfunction through microbiota-dependence and Wnt/β-catenin pathway.
Dong Y; Fan H; Zhang Z; Jiang F; Li M; Zhou H; Guo W; Zhang Z; Kang Z; Gui Y; Shou Z; Li J; Zhu R; Fu Y; Sarapultsev A; Wang H; Luo S; Zhang G; Hu D
Int J Biol Sci; 2022; 18(4):1381-1397. PubMed ID: 35280677
[TBL] [Abstract][Full Text] [Related]
11. The berberine-enriched gut commensal Blautia producta ameliorates high-fat diet (HFD)-induced hyperlipidemia and stimulates liver LDLR expression.
Yang YN; Wang QC; Xu W; Yu J; Zhang H; Wu C
Biomed Pharmacother; 2022 Nov; 155():113749. PubMed ID: 36174380
[TBL] [Abstract][Full Text] [Related]
12. Effect of berberine on hyperglycaemia and gut microbiota composition in type 2 diabetic Goto-Kakizaki rats.
Zhao JD; Li Y; Sun M; Yu CJ; Li JY; Wang SH; Yang D; Guo CL; Du X; Zhang WJ; Cheng RD; Diao XC; Fang ZH
World J Gastroenterol; 2021 Feb; 27(8):708-724. PubMed ID: 33716449
[TBL] [Abstract][Full Text] [Related]
13. Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation.
Porras D; Nistal E; Martínez-Flórez S; Pisonero-Vaquero S; Olcoz JL; Jover R; González-Gallego J; García-Mediavilla MV; Sánchez-Campos S
Free Radic Biol Med; 2017 Jan; 102():188-202. PubMed ID: 27890642
[TBL] [Abstract][Full Text] [Related]
14. Berberine-induced bioactive metabolites of the gut microbiota improve energy metabolism.
Wang Y; Shou JW; Li XY; Zhao ZX; Fu J; He CY; Feng R; Ma C; Wen BY; Guo F; Yang XY; Han YX; Wang LL; Tong Q; You XF; Lin Y; Kong WJ; Si SY; Jiang JD
Metabolism; 2017 May; 70():72-84. PubMed ID: 28403947
[TBL] [Abstract][Full Text] [Related]
15. Antidiabetic Effects of Gegen Qinlian Decoction via the Gut Microbiota Are Attributable to Its Key Ingredient Berberine.
Xu X; Gao Z; Yang F; Yang Y; Chen L; Han L; Zhao N; Xu J; Wang X; Ma Y; Shu L; Hu X; Lyu N; Pan Y; Zhu B; Zhao L; Tong X; Wang J
Genomics Proteomics Bioinformatics; 2020 Dec; 18(6):721-736. PubMed ID: 33359679
[TBL] [Abstract][Full Text] [Related]
16. Oxyberberine, a novel gut microbiota-mediated metabolite of berberine, possesses superior anti-colitis effect: Impact on intestinal epithelial barrier, gut microbiota profile and TLR4-MyD88-NF-κB pathway.
Li C; Ai G; Wang Y; Lu Q; Luo C; Tan L; Lin G; Liu Y; Li Y; Zeng H; Chen J; Lin Z; Xian Y; Huang X; Xie J; Su Z
Pharmacol Res; 2020 Feb; 152():104603. PubMed ID: 31863867
[TBL] [Abstract][Full Text] [Related]
17. The Potential Mechanisms of Berberine in the Treatment of Nonalcoholic Fatty Liver Disease.
Zhu X; Bian H; Gao X
Molecules; 2016 Oct; 21(10):. PubMed ID: 27754444
[TBL] [Abstract][Full Text] [Related]
18. Berberine ameliorates ovariectomy-induced anxiety-like behaviors by enrichment in equol generating gut microbiota.
Fang Y; Zhang J; Zhu S; He M; Ma S; Jia Q; Sun Q; Song L; Wang Y; Duan L
Pharmacol Res; 2021 Mar; 165():105439. PubMed ID: 33493658
[TBL] [Abstract][Full Text] [Related]
19. Berberine Protects against High-Energy and Low-Protein Diet-Induced Hepatic Steatosis: Modulation of Gut Microbiota and Bile Acid Metabolism in Laying Hens.
Wang C; Yang Y; Chen J; Dai X; Xing C; Zhang C; Cao H; Guo X; Hu G; Zhuang Y
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139133
[TBL] [Abstract][Full Text] [Related]
20. Transforming berberine into its intestine-absorbable form by the gut microbiota.
Feng R; Shou JW; Zhao ZX; He CY; Ma C; Huang M; Fu J; Tan XS; Li XY; Wen BY; Chen X; Yang XY; Ren G; Lin Y; Chen Y; You XF; Wang Y; Jiang JD
Sci Rep; 2015 Jul; 5():12155. PubMed ID: 26174047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
